Saturday, August 27, 2016

"Just Co-Incidence", Epi-Pen (Part Two)

Yesterday we learned that the CEO of Mylan/Epi-Pen is the daughter of US Senator Manchin (D).  Heather Bresch was well-paid for her position:  about $19,000,000.00 in 2015.

This was while Epi-Pen's price increased by near 500%.

In another *co-incidence*, the company scored a LARGE increase in revenues from the US Government just after The Daughter took over, from $0 in 2012 to $1.5 million in 2014.

And in a third *co-incidence* we find that the FDA has granted Ms. Bresch's company a monopoly on this treatment.  FDA is another of the sprawl of Gummint agencies, of course.

No doubt that all of this is perfectly legal.

So is the Clinton Foundation.

No comments: